Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:JPMorgan Unveils its Latest Fund Not Rated 0.0 Email Routing List Email & Route  Print Print
Thursday, September 9, 2010

JPMorgan Unveils its Latest Fund

Reported by Armie Margaret Lee

George Gatch & co. have expanded their mutual fund roster. On Thursday, JPMorgan [see profile] formally unveiled the JPMorgan Research Equity Long/Short Fund. [ SEC filing]

Terance Chen
JPMorgan Funds
Portfolio Manager
The fund seeks to provide exposure to equity-like returns while aiming to reduce downside risk. It shoots for "a third to half the volatility of a typical S&P 500 product," said portfolio manager Terance Chen in an interview with The MFWire.com.

"This is a concept we've been thinking about for a while," Chen said. "We've been incubating a similar strategy for a little less than two years."

Demand prompted JPMorgan to offer the fund in a '40 Act format, he said.

"We started this strategy for institutional investors and we got feedback from people saying that it's a great idea and we should deliver that in a retail format," Chen said.

Expense ratios are 340 basis points for A shares (JLSAX), 390 bps for C shares (JLSCX) and 315 bps for Select Class Shares (JLSSX).
Company Press Release

NEW YORK, Sept. 9 / -- J.P. Morgan Funds, the mutual fund arm of JPMorgan Chase & Co. (NYSE: JPM) has launched a new equities mutual fund, the JP Morgan Research Equity Long/Short Fund (A shares: JLSAX).

The Research Equity Long/Short Fund seeks to provide individual investors with exposure to equity-like returns while striving to reduce downside risk and limit volatility, offering a more conservative approach for investors returning to equities.

The fund is managed by senior portfolio manager Terance Chen, who has more than 16 years of investment experience at J.P. Morgan and who is also lead manager of the JP Morgan Research Market Neutral Fund (A shares: JMNAX). The Research Equity Long/Short Fund is also backed by the insights of more than 30 career research analysts, giving it a significant research advantage in identifying undervalued and overvalued securities.

In order to provide long term capital appreciation, the fund engages in the following strategies:

  • Using the research team's insights, the portfolio invests in attractively valued securities, offset by short positions in stocks which appear expensive. Long/short pair trades within sectors aims to generate returns while minimizing volatility.
  • Maintains a relatively low net market exposure to minimize market risk while emphasizing bottoms-up, fundamental stock selection in generating returns
  • The Fund invests primarily in U.S. securities and does not employ leverage or use of derivatives, beyond cash futures.

    "The JP Morgan Research Equity Long/Short Fund provides another option for diversification as investors adjust their current portfolio for new market realities," said George Gatch, CEO of J.P. Morgan Investment Management Americas. "This fund is a dynamic alternative to typical approaches found in pure market neutral strategies, while seeking to provide low correlation to equity and bond markets."

    J.P. Morgan Funds is 2nd in net flows for all U.S. mutual fund companies as of 7/31/10 and is the 4th largest mutual fund firm in the U.S., with $393 billion in assets under management (according to Morningstar, as of 7/31/10). It offers over 100 mutual fund products across the full range of asset classes, as well as separately managed accounts and retirement products.
  •  

    Stay ahead of the news ... Sign up for our email alerts now
    CLICK HERE

    0.0
     Do You Recommend This Story?



    GO TO: MFWire
    Return to Top
     News Archives
    2025: Q1
    2024: Q4Q3Q2Q1
    2023: Q4Q3Q2Q1
    2022: Q4Q3Q2Q1
    2021: Q4Q3Q2Q1
    2020: Q4Q3Q2Q1
    2019: Q4Q3Q2Q1
    2018: Q4Q3Q2Q1
    2017: Q4Q3Q2Q1
    2016: Q4Q3Q2Q1
    2015: Q4Q3Q2Q1
    2014: Q4Q3Q2Q1
    2013: Q4Q3Q2Q1
    2012: Q4Q3Q2Q1
    2011: Q4Q3Q2Q1
    2010: Q4Q3Q2Q1
    2009: Q4Q3Q2Q1
    2008: Q4Q3Q2Q1
    2007: Q4Q3Q2Q1
    2006: Q4Q3Q2Q1
    2005: Q4Q3Q2Q1
    2004: Q4Q3Q2Q1
    2003: Q4Q3Q2Q1
    2002: Q4Q3Q2Q1
     Subscribe via RSS:
    Raw XML
    Add to My Yahoo!
    follow us in feedly


    1. MFDF webinar - 2024 Fair Valuation Pricing Survey: Building and Strengthening the Valuation Operating Model, January 7
    2. WE - Trailblazing Leaderships: Insights From Los Angeles' Leading Women CEOs, January 8
    3. MFDF webinar - 15(c) White Paper Webinar Series: Part 2 – Board Processes, January 9
    4. MFDF webinar - AI and Fund Compliance, January 21
    5. MFDF In Focus - In Focus: Small Boards' Use of Skills Matrices, January 22
    6. FSI OneVoice 2025, Jan 27-29
    7. MFDF 2025 Directors' Institute, Jan 27-29
    8. Nicsa webinar - An Intro to Irish and Luxembourg Investment Platforms for US Asset Managers, January 29
    9. 2025 ICI Innovate, Feb 3-5
    10. Nicsa webinar - AI In Operations: Boosting Productivity for Wealth & Asset Management Firms, February 5
    11. MFDF Director Discussion Series - Open Forum, February 10
    12. MFDF Director Discussion Series - Open Forum, February 11
    13. Expect Miracles In Manhattan 2025, February 27
    14. Citywire Scottsdale CIO Summit 2025, Feb 27-28
    15. T3 Technology Conference 2025, Mar 3-6
    16. Nicsa 2025 Strategic Leadership Forum, Mar 5-7
    17. MFDF 2025 Fund Governance & Regulatory Insights Conference, Mar 6-7
    18. Citywire Pro Buyer New York Due Diligence Retreat 2025, Mar 6-7
    19. 2025 MMI Summit, Mar 27-28
    20. MFDF Director Discussion Series - Open Forum, April 2
    21. Envestnet Elevate 2025, Apr 9-10
    22. MFDF Director Discussion Series - Open Forum, April 15
    23. The 36th Sub-Advised Funds Forum, Apr 29-30
    24. Expect Miracles 6th Annual Distance Challenge, May 13-20
    25. Morningstar Investment Conference 2025, Jun 25-26
    26. MFDF Director Discussion Series - Open Forum, July 9




    ©All rights reserved to InvestmentWires, Inc. 1997-2025
    14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
    Privacy Policy :: Terms of Use